PLCB1 and Alzheimer disease: Although the disruption of PLCβ1-mediated signaling in the brain is associated with epilepsy, schizophrenia, and bipolar disorder [72–74], to the best of our knowledge, our results provide the first direct evidence of the disruption of the hippocampal PLCβ1 pathway in a rodent model of AD.